Cantor Fitzgerald Maintains Overweight on Alkermes, Raises Price Target to $48
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Charles Duncan maintains an Overweight rating on Alkermes (NASDAQ:ALKS) and raises the price target from $43 to $48.
May 23, 2024 | 3:44 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Charles Duncan maintains an Overweight rating on Alkermes and raises the price target from $43 to $48.
The raised price target and maintained Overweight rating from a reputable analyst at Cantor Fitzgerald is likely to positively influence investor sentiment and drive short-term price appreciation for Alkermes.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100